Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 StudyLuis Paz‐Ares, C. Chouaïd, Nicolas Girard et al.|Journal of Clinical Oncology|2024Cited by 126
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study ProtocolBenjamin Levy, Jonathan W. Riess, Luis Paz‐Ares et al.|Clinical Lung Cancer|2019Cited by 10
A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non–small cell lung cancer: HARMONi-3.Jianjun Zhang, Shun Lu, Jun Cai et al.|Journal of Clinical Oncology|2025Cited by 2